Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO
Biotech company Metsera, which develops weight-loss drugs and is backed by ARCH Venture Partners, said on Monday that it is ...
These Stocks Are Moving the Most Today: Nvidia, Broadcom, GE Vernova, Vistra, AT&T, SoFi, Akero, Tesla, and More
Shares of Nvidia, Broadcom, and ASML slump as China’s DeepSeek threatens the companies’ dominance in artificial intelligence, ...